[1]
“Efficacy and safety of a new mometasone furoate nasal spray formulation in patients with acute rhinosinusitis: a randomized clinical trial”, Ital J Med, vol. 16, no. 1, Nov. 2022, doi: 10.4081/itjm.2022.1533.